Replies to post #180205 on Biotech Values

[DewDiligence]

I’m holding off on considering a BAX purchase until more information becomes available about the split-up, particularly with respect to the balance sheets of the successor companies.

BAX’s pharma successor company will become MNTA’s FoB partner (#msg-70212854).